s

Since January 22nd, 2026, Accellix is part of bioMérieux, a world leader in the field of in vitro diagnostics.

Learn more about this strategic acquisition.

WATCH PRESENTATION

Value of the QC testing in ATMP: when rapid time to results matters

To Access Video, Please Complete this Form:

    Interest*